Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Abbvie Inc

Recent news which mentions Abbvie Inc

< Previous 1 2 Next >
Trump's drug price ultimatum sets pharma firms scrambling
Tags Pharmaceuticals Regeneron Pharmaceuticals Inc Gilead Sciences Inc
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags Biogen Inc Pfizer Inc Health care industry
From CNBC.com News
Trump threatens to put up to 200% tariff on pharmaceuticals 'very soon'
Tags Breaking News: Business Business News Pharmaceuticals
From CNBC.com News
Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan
Tags Merck & Co Inc Abbvie Inc Breaking News: Business
From CNBC.com News
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
Tags Breaking News: Business Abbvie Inc Merck & Co Inc
From CNBC.com News
Jim Cramer suggests why it's hard to own traditional 'safety' stocks here
Tags Stock Picks Procter & Gamble Co PepsiCo Inc/
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Roche Holding AG Business News LILLY DRN
From CNBC.com News
Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
Tags Abbvie Inc Breaking News: Business LILLY DRN
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Mergers Roche Holding AG LILLY DRN
From CNBC.com News
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Tags LILLY DRN Merck & Co Inc Abbvie Inc
From CNBC.com News
Cramer's week ahead: Earnings from Tesla, Alphabet, Capital One and Boeing
Tags Lockheed Martin Corp Agnico Eagle Mines Ltd Investment strategy
From CNBC.com News
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
Tags Business Amgen Inc Johnson & Johnson
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Breaking News: Markets Moderna Inc LILLY DRN
From CNBC.com News
Ad spending on women's sports more than doubled last year
Tags Business News McDonald's Corp Marketing and advertising
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags AstraZeneca PLC Salesforce Inc Biotech and Pharmaceuticals
From CNBC.com News
Cramer's Lighting Round: AbbVie is a buy
Tags Cerence Inc Market Outlook Stock Picks
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Social issues Business Amgen Inc
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Pultegroup Inc Microsoft Corp Advanced Micro Devices Inc
From CNBC.com News
Cramer's Lightning Round: Sweetgreen is 'terrific'
Tags Oracle Corp stocks Investing
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags HCA Holdings Inc Stock markets Arch Capital Group Ltd
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Abbvie Inc Merck & Co Inc Politics
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Healthy Returns Politics Abbvie Inc
From CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
Tags Abbvie Inc Alvotech SA UnitedHealth Group Inc
From CNBC.com News
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
Tags US: News Business Abbott Laboratories
From CNBC.com News
After 8 months stuck in orbit, Varda's drug spacecraft gets FAA approval to return
Tags Space Space industry Business
From CNBC.com News
Cramer's Lightning Round: AbbVie is 'a very good company'
Tags Investment strategy Mad Money Abbvie Inc
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Tags Business US: News Amgen Inc
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
Tags Health & Science Ambrx Biopharma Inc Biotech and Pharmaceuticals
From CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
Tags Roche Holding AG Investment Strategy AstraZeneca PLC
From CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
Tags Pfizer Inc Pharmaceuticals Bristol/Myers Squibb Co
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.